• UCLA Health
  • myUCLAhealth
  • School of Medicine
Institute of Urologic Oncology

UCLA Institute of Urologic Oncology

Institute of Urologic Oncology
  • About Us
    • Director's Welcome
    • Board of Directors
    • IUO in the News
    • Why Choose the UCLA IUO
    • Support the IUO
    • Contact Us
    • The Wasserman Building
    • Maps and Directions
    • IUO Membership Information
    • Administrative & Research Staff
    • Positions Available
  • Clinical Programs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • Testicular Cancer
    • Integrated Cancer Program
    • Cancer Genetic Risk Assessment Program
  • Research Programs
    • Clinical Trials
    • Faculty Labs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • SPORE In Prostate Cancer
    • External Funding Opportunities
    • Webinars / Videos
  • Clinical Trials
    • What Is a Clinical Trial?
    • Who Should Consider Clinical Trials & Why
    • Bladder Cancer Clinical Trials
    • Kidney Cancer Clinical Trials
    • Prostate Cancer Clinical Trials
    • Clinical Research Team
    • IUO Membership Study Information
  • For Patients
    • Contact Us
    • Clinical Updates
    • Health Plans and Financial Matters
    • Maps and Directions
    • myUCLAhealth
    • Patient Testimonials
    • Preparing for Surgery
    • Webinars / Videos
  • Fellowship
    • Current Fellows
    • Former Fellows
    • Fellow Testimonials
    • UCLA Health Aerial Tour
  • For Healthcare Professionals
    • How to Refer a Patient
    • Lectures & Conferences
    • CTSI Distinguished Speaker Seminar Series
    • DGSOM Research Seminars
    • DGSOM Events
    • JCCC Seminars
    • SPORE Lectures
    • External Funding Opportunities
  • Expert Team
    • Board of Directors
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Institute of Urologic Oncology

Clinical Trials

Clinical Trials

Clinical Trials

  • What Is a Clinical Trial?
  • Who Should Consider Clinical Trials & Why
  • Bladder Cancer Clinical Trials
  • Kidney Cancer Clinical Trials
  • Prostate Cancer Clinical Trials
  • Clinical Research Team
  • IUO Membership Study Information
  • What Is a Clinical Trial?
  • Who Should Consider Clinical Trials & Why
  • Bladder Cancer Clinical Trials
  • Kidney Cancer Clinical Trials
  • Prostate Cancer Clinical Trials
  • Clinical Research Team
  • IUO Membership Study Information
  1. Home
  2. Institute of Urologic Oncology
  3. Clinical Trials
  4. Prostate Cancer Clinical Trials

Prostate Cancer Clinical Trials

Share this

Treatment Studies

Clinically Localized

  • Active Surveillance for Cancer of the Prostate (ASCAP)
  • MIRAGE Protocol for Prostate Cancer
  • GARUDA Study for Prostate Cancer
  • Targeted Ultrasound Ablation for Treatment  of Localized  Prostate Cancer

Neoadjuvant/adjuvant (before/after your primary cancer treatment)

  • Short-Course of Radiotherapy Following Prostatectomy for Men with Advanced Prostate Cancer
  • A Study for Men with Prostate Cancer who are Candidates for Radical Prostatectomy

Metastatic, Castration-Sensitive

  • Systemic and Directed Therapy for Recurrent Prostate Cancer

Metastatic, Castration-Resistant (mCRPC)

  • A Study Using the Research Drug Talazoparib with Enzalutamide to Treat Your Prostate Cancer
  • A Study of FOR46 Given Every 21 Days for the Treatment of Your Prostate Cancer
  • A Study Using the Research Drug AMG 160 to Treat Your Prostate Cancer
  • A New Study to Treat Prostate Cancer in People who have Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and DNA Repair Defects
  • KEYNOTE-641: A Study comparing Enzalutamide with or without Pembrolizumab in Metastatic Prostate Cancer
  • KEYLYNK-010: A Study comparing Pembrolizumab plus Olaparib versus Abiraterone Acetate or Enzalutamide to treat Metastatic Prostate Cancer
  • A Study Evaluating the Safety and Effectiveness of AB928-BasedTreatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC) 

  • A Study Evaluating the Safety of a new drug (ARV-110) in Patients with Metastatic Castration-Resistant Prostate Cancer

  • A Study Assessing the Safety of a new drug (MGC018) in Patients with Solid Tumors

  • CheckMate 7DX: A Study comparing Docetaxel with or without Nivolumab in Metastatic Prostate Cancer

Other

  • Pembrolizumab with Chemo in Urothelial and Prostate Cancers
  • KEYNOTE-991: A Phase 3 Study for Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 


Imaging Studies

  • An imaging study to evaluate the effects of hormonal treatments on prostate cancer imaging with PSMA PET
  • An Experimental Imaging Scan to Treat Your Prostate Cancer Recurrence with Radiation Therapy
  • Expanded Access Protocol of 68Ga-PSMA-11 for Prostate Cancer PET Imaging (EAP)
  • An imaging study of 68Ga-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients with Prostate Cancer (BASKET)
  • A randomized imaging study of PSMA PET scan before definitive radiation therapy in patients with unfavorable IR or HR prostate cancer (PSMA PyL dRT)
  • A prospective exploratory imaging study of 68Ga-FAPI-46 PET/CT Scan in Patients with Prostate Cancer (FAPI Prostate)

Observational and Biospecimen Studies

  • GU Cancer Repository Study
  • A Registry for Men with Advanced Prostate Cancer
  • Cryoablation Study
  • Fusion Biopsy: Prostate Cancer Imaging (Fusion Biopsy Stidy)
  • High-intensity Focused Ultrasound Study
  • Hypo-fractionated Stereotactic Body Radiotherapy in High Risk Prostate Cancer

Other

  • HITCH: Male Veterans Hospitalized Due to COVID-19 Illness

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest